You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Exploring innovative regulatory pathways: a US perspective
- In: Symposium D1: New approaches of regulating innovative medicines on Monday, 22 May 2017, 15:45-16:20
- At: Stockholm (Sweden) (2017)
- Type: Presentation
- By: LIBERTI, Lawrence (CIRS, Holland, United States)
- Co-author(s): Lawrence Liberti: CIRS, Holland, United States
- Abstract:
Pharmaceutical innovation results from the efficient partnership between drug developers, regulators, payers and patients among others stakeholders. A regulatory agency, with the support of its legislature, can stimulate and support innovation through the active application of various elements of regulatory science. In the US, programmes have
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026